Related Experiment Video
Updated: Jul 4, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
Consistent control of mineral and bone disorder in incident hemodialysis patients
Mark D Danese1, Vasily Belozeroff, Karen Smirnakis
1Outcomes Insights, Inc., Newbury Park, California, USA. mark@outins.com
Insights
Maintaining target levels for parathyroid hormone, calcium, and phosphorus is crucial for hemodialysis patients. Consistent control of these bone metabolism markers significantly improves survival rates.
Area of Science:
- Nephrology
- Mineral and Bone Disorder
- Clinical Outcomes
Background:
- National Kidney Foundation guidelines (2003) recommend targets for parathyroid hormone, calcium, and phosphorus in hemodialysis patients.
- Mineral and bone disorder is a common complication in patients undergoing hemodialysis.
Purpose of the Study:
- To investigate the association between consistent control of mineral and bone disorder markers and mortality risk in hemodialysis patients.
- To evaluate the impact of achieving target levels for parathyroid hormone, calcium, and phosphorus on patient survival.
Main Methods:
- A cohort study of 22,937 incident hemodialysis patients was conducted.
- Patients were followed for mortality risk assessment using Cox proportional hazards models.
- Consistent achievement was defined as simultaneous control of multiple markers and time in target during the first year of dialysis.
Main Results:
- Achieving target for all three markers (parathyroid hormone, calcium, phosphorus) was associated with a lower mortality risk compared to achieving none.
- Patients with sustained control of parathyroid hormone, calcium, or phosphorus showed significantly reduced mortality risk.
- Higher risk of death was observed with less consistent control of these key bone metabolism markers.
Conclusions:
- Consistent control of parathyroid hormone, calcium, and phosphorus levels is a significant predictor of survival in hemodialysis patients.
- Adherence to established guidelines for mineral and bone disorder management can improve long-term outcomes.
Background And Objectives:
In 2003, the National Kidney Foundation introduced guidelines for the control of parathyroid hormone, calcium, and phosphorus in hemodialysis patients.
Design, Setting, Participants, & Measurements:
A cohort study was conducted of 22,937 incident hemodialysis patients who were identified from a large national provider between July 1, 2000, and June 30, 2002, and followed through June 30, 2004. Consistent achievement was determined (1) as the simultaneous control of multiple markers over time and (2) as the time in target for each marker during the first year of dialysis. Mortality risk was assessed with Cox proportional hazards models.
Results:
In the simultaneous control analysis, patients who achieved target for none of the markers had a 51% greater risk for death than those who achieved target for all three markers (reference group). Patients who achieved any target for any single marker had a 35 to 39% higher risk for death, and patients who achieved target for any two of the three markers had a 15 to 21% higher risk for death compared with the reference group. In the time in target analysis, patients with parathyroid hormone in target for 4 quarters had a 25% lower risk for death compared with those who did so for
Conclusions:
Consistent control of the markers of bone metabolism and disease within published targets is a strong predictor of survival in hemodialysis patients.
Related Concept Videos
Hemodialysis III: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Peritoneal Dialysis III: Nursing Management
Chronic Kidney Disease IV: Nursing Management
Hemodialysis II: Procedure and Complications
Chronic Kidney Disease II: Clinical Manifestations